BLZF1
Golgin-45
Also known as: GO45_HUMAN, JEM-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H2G9
- Gene
- BLZF1
- Ensembl
- ENSG00000117475
- Chromosome
- 1
- Canonical length
- 400 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
Enables ubiquitin protein ligase binding activity. Acts upstream of or within Golgi organization and Golgi to plasma membrane protein transport. Located in Golgi apparatus and nucleoplasm. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
400 residues, UniProt reviewed canonical sequence.
>Q9H2G9|BLZF1
1 MTTKNLETKV TVTSSPIRGA GDGMETEEPP KSVEVTSGVQ SRKHHSLQSP WKKAVPSESP
61 GVLQLGKMLT EKAMEVKAVR ILVPKAAITH DIPNKNTKVK SLGHHKGEFL GQSEGVIEPN
121 KELSEVKNVL EKLKNSERRL LQDKEGLSNQ LRVQTEVNRE LKKLLVASVG DDLQYHFERL
181 AREKNQLILE NEALGRNTAQ LSEQLERMSI QCDVWRSKFL ASRVMADELT NSRAALQRQN
241 RDAHGAIQDL LSEREQFRQE MIATQKLLEE LLVSLQWGRE QTYSPSVQPH STAELALTNH
301 KLAKAVNSHL LGNVGINNQK KIPSTVEFCS TPAEKMAETV LRILDPVTCK ESSPDNPFFE
361 SSPTTLLATK KNIGRFHPYT RYENITFNCC NHCRGELIALLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BLZF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 33 nTPM
Expression across tissuesHPA
Tissue
- testis: 33 nTPM
- esophagus: 30 nTPM
- bone marrow: 24 nTPM
- retina: 21 nTPM
- breast: 18 nTPM
- thyroid gland: 18 nTPM
Single-cell type
- esophageal apical cells: 314 nCPM
- late primary spermatocytes: 181 nCPM
- epididymal basal cells: 180 nCPM
- early spermatids: 137 nCPM
- ocular epithelial cells: 116 nCPM
- urothelial cells: 113 nCPM
Immune cell
- basophil: 86 nTPM
- eosinophil: 52 nTPM
- neutrophil: 25 nTPM
- T-reg: 24 nTPM
- NK-cell: 20 nTPM
- intermediate monocyte: 16 nTPM
Brain region
- white matter: 34 nTPM
- cerebellum: 30 nTPM
- basal ganglia: 27 nTPM
- medulla oblongata: 27 nTPM
- spinal cord: 27 nTPM
- cerebral cortex: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.41
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 11% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- DASH complex subunit Hsk3-like
- Golgin-45
- DASH complex subunit Hsk3 like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BLZF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BLZF1 as an antibody target. Whether an autoantibody or antibody against BLZF1 could matter depends on whether native BLZF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BLZF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BLZF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...